FDA inspection
Richard W. Foltin, Ph.D.: FDA inspection ending Mar 17, 2023
FDA inspection 1199985 · Official Action Indicated (OAI) · New York, NY
Key facts
| Inspection ID | 1199985 |
|---|---|
| Firm | Richard W. Foltin, Ph.D. |
| FEI number | 3003469576 |
| Address | 1051 Riverside Dr Unit 120 |
| City | New York |
| State | NY |
| ZIP | 10032 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Mar 17, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
| Warning letter | 690189 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data